Using a light-sensitizing drug to find cancer in the upper urinary tract
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether taking a drug called 5-ALA before a scope procedure helps doctors spot cancer cells in the upper urinary tract more clearly. If you are having a scope to check for or treat a tumor in this area, this experimental imaging method might help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled for a scope procedure (ureteroscopy) to check for or treat a tumor in the upper urinary tract
- You are willing to follow study rules and give your consent
- You are not pregnant or breastfeeding
- You do not have a blood disorder called porphyria or an allergy to related drugs
- You have not taken part in another research study in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a procedure done in the clinic, without general anesthesia, can safely check the upper urinary tract after kidney-sparing surgery for urothelial cancer. It may reduce the need for hospital visits.
This trial tests whether a special dye, taken as a drink before surgery, makes kidney cancer cells glow under a fluorescent light. This may help surgeons remove the tumor more completely while saving healthy kidney tissue.
This trial tests a new, disposable flexible camera (ureteroscope) to safely check for or monitor upper urinary tract cancer in an office setting without putting you to sleep. The goal is to see if patients can tolerate this procedure comfortably while awake.
This trial tests combining the immunotherapy drug pembrolizumab with BCG, a standard treatment for bladder cancer, after a scope procedure to remove high-grade cancer from the upper urinary tract. It aims to lower the chance of cancer coming back without needing to remove the kidney.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
Hear when a new Upper Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.